LICR

(redirected from Ludwig Institute for Cancer Research)
Also found in: Wikipedia.
AcronymDefinition
LICRLudwig Institute for Cancer Research
LICRLaboratory-Initiated CD4 (Cluster Difference 4) Reporting (AIDS surveillance methods)
References in periodicals archive ?
The Ludwig Institute for Cancer Research is the largest international academic institute dedicated to understanding and controlling cancer.
Andrew Simpson of the Ludwig Institute for Cancer Research in New York lauded the new developments "The approach developed by Reiter and his colleagues is a significant new approach to cancer immunotherapy," said Simpson.
Inserting the light source directly into the cells makes it possible to attack tumors deep in the body without using an outside light source that could damage healthy tissue on the way, according to researchers at University College London and the Ludwig Institute for Cancer Research.
A team from the Ludwig Institute for Cancer Research and the Breakthrough breast cancer charity found altered breast genes in some patients which could undermine the success of cancer treatments such as Herceptin.
* Determining the Function and Regulation of the Putative Guanine Nucleotide Exchange Factor Alsin in Motor Neuron Degeneration Christine Vande Velde, Investigator Ludwig Institute for Cancer Research, La Jolla, Calif.
The non-adherent RPMI-8866 and adherent MDAMB-453 cell lines, which were obtained from the Iran cell bank, Pasteur Institute (Tebran, Iran) and Ludwig Institute for cancer research (London, U.K.) were cultivated respectively at densities of [10.sup.6] cells/ml in 15 ml of media 199 with Earle's salt (E-199) and RPMJ 1640 (Gibco, Germany) containing 100 IU/ml Penicillin and 50 [micro]/ml Gentamycine and were kept in an incubator with a moist atmosphere containing 5% [CO.sub.2] at 37 [degrees]C.
The Ludwig Institute for Cancer Research is evaluating the first application of Gyros AB's sample prep CD technology ...
Simpson of the Ludwig Institute for Cancer Research at Sao Paulo is coordinating the Brazilian research to "determine the exact sequence of the units, known as nucleotide pairs, that make up each X.
"This is the first time that a [cancer-cell] antigen recognized by [immune-system cells] has been identified," asserts Thierry Boon, of the Ludwig Institute for Cancer Research in Brussels.
According to the contract, Medigene will acquire access to the NTAmer technology that has been developed by TCMetrix, a spin-off firm of the Ludwig Institute for Cancer Research in Lausanne.
Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine.